全文获取类型
收费全文 | 9288篇 |
免费 | 581篇 |
国内免费 | 181篇 |
专业分类
耳鼻咽喉 | 531篇 |
儿科学 | 227篇 |
妇产科学 | 324篇 |
基础医学 | 967篇 |
口腔科学 | 132篇 |
临床医学 | 1387篇 |
内科学 | 702篇 |
皮肤病学 | 58篇 |
神经病学 | 235篇 |
特种医学 | 300篇 |
外国民族医学 | 1篇 |
外科学 | 1348篇 |
综合类 | 1410篇 |
预防医学 | 883篇 |
眼科学 | 259篇 |
药学 | 834篇 |
7篇 | |
中国医学 | 221篇 |
肿瘤学 | 224篇 |
出版年
2024年 | 8篇 |
2023年 | 113篇 |
2022年 | 249篇 |
2021年 | 365篇 |
2020年 | 330篇 |
2019年 | 275篇 |
2018年 | 292篇 |
2017年 | 323篇 |
2016年 | 305篇 |
2015年 | 296篇 |
2014年 | 676篇 |
2013年 | 675篇 |
2012年 | 641篇 |
2011年 | 679篇 |
2010年 | 519篇 |
2009年 | 460篇 |
2008年 | 406篇 |
2007年 | 440篇 |
2006年 | 377篇 |
2005年 | 371篇 |
2004年 | 283篇 |
2003年 | 234篇 |
2002年 | 181篇 |
2001年 | 164篇 |
2000年 | 150篇 |
1999年 | 124篇 |
1998年 | 129篇 |
1997年 | 90篇 |
1996年 | 99篇 |
1995年 | 90篇 |
1994年 | 88篇 |
1993年 | 55篇 |
1992年 | 55篇 |
1991年 | 50篇 |
1990年 | 46篇 |
1989年 | 45篇 |
1988年 | 37篇 |
1987年 | 35篇 |
1986年 | 35篇 |
1985年 | 55篇 |
1984年 | 42篇 |
1983年 | 35篇 |
1982年 | 26篇 |
1981年 | 20篇 |
1980年 | 24篇 |
1979年 | 15篇 |
1978年 | 17篇 |
1977年 | 6篇 |
1976年 | 8篇 |
1973年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
《Journal of vascular and interventional radiology : JVIR》2022,33(6):660-667
PurposeTo investigate the safety and efficacy of an aqueous polyethylene glycol-based liquid embolic agent, Embrace Hydrogel Embolic System (HES), in the treatment of benign and malignant hypervascular tumors.Materials and MethodsA prospective, single-arm, multicenter study included 8 patients, 5 males and 3 females, with a median age of 58.5 years (30–85 years), who underwent embolization in 8 tumors between October 2019 and May 2020. Technical success was defined as successful delivery of HES to the index vessel, with disappearance of >90% of the targeted vascular enhancement or, for portal vein embolization, occlusion of the portal branches to the liver segments for future resection. The volume of HES administered, ease of use (5 point Likert scale), administration time, and adverse events (AEs) were recorded. Evaluation was performed at 7, 30, and 90 days via clinical assessment and blood testing, and follow-up imaging was performed at 30 days.ResultsEight patients were enrolled, and 10 embolizations were performed in 8 lesions. Tumors included hepatocellular carcinoma (n = 4), renal angiomyolipoma (n = 3), and intrahepatic cholangiocarcinoma (n = 1). Technical success was 100%, and the average ease of use was 3.3 ± 1.0 SD. The HES delivery time was 1–28 minutes (median, 16.5 minutes), and the HES volume injected was 0.4–4.0 mL (median, 1.3 mL). All patients reached 30-day follow-up with imaging, and 6 patients reached 90-day follow-up. There were 3 serious AEs in 2 patients that were unrelated to the embolic agent.ConclusionHES resulted in a 100% embolization technical success rate. The product ease of use was acceptable, and no target vessel recanalization was noted on follow-up imaging at 30 days. 相似文献
2.
《The Journal of arthroplasty》2022,37(3):468-475
BackgroundUltracongruent (UC) tibial inserts can increase knee replacement stability, but how survivorship compares to cruciate retaining (CR) or posterior stabilized (PS) inserts is unclear.MethodsData from a large joint registry were used to calculate the cumulative percent revision of a single popular knee design used with different inserts. There were 67,523 procedures, of which 12,434 were UC, 21,635 CR, and 33,454 PS. Revision rates and reasons for revision were analyzed.ResultsThe cumulative percent revision at 18 years was 8.3% for UC, 9.2% for CR, and 8.9% for PS. There was no difference when UC was compared to CR, but PS had a higher risk of revision. Revision reasons were similar.ConclusionCompared to the CR, an UC insert did not increase revision rates and was actually lower than a PS insert. An UC insert does not compromise long-term total knee arthroplasty survivorship in the Genesis II prosthesis. 相似文献
3.
目的探讨改良双腔球囊导管在插管失败的输卵管阻塞介入再通术中的应用价值。方法回顾45例输卵管阻塞性不孕患者,应用常规法行介入再通术,其中输卵管开口插管失败采用改良双腔球囊导管行介入再通,统计分析常规法组与联合改良双腔球囊导管法组(联合法组)的输卵管开口插管成功率、输卵管阻塞的开通率。结果输卵管阻塞性不孕患者45例,共阻塞输卵管90条,采用常规法输卵管开口插管成功32条,其中开通成功31条,插管成功率为35.56%,开通率96.88%。采用联合法输卵管开口插管成功90条,输卵管开通83条,插管成功率为100%,开通率92.22%,7条输卵管因阻塞病情严重无法开通,其中双侧均未能开通1例。所有患者术中均无严重并发症发生。随访12个月,妊娠率48.65%。常规法组与联合法组输卵管开口插管成功率差异具有统计学意义(χ^2=85.574,P=0.000),而输卵管开通率差异无统计学意义(χ^2=0.248,P=0.619)。结论对于常规法输卵管开口插管失败者,采用联合改良双腔球囊导管可提高输卵管开口插管成功率。采用改良双腔球囊导管介入再通与常规法开通效果相当,可作为常规介入再通输卵管开口插管失败的备选方案。 相似文献
4.
5.
《Journal of pharmaceutical sciences》2019,108(10):3425-3433
This study aimed at evaluating how encapsulation in a regular nanocarrier (NC) (providing extended circulation time) or in a brain-targeting NC (providing prolonged circulation time and increased brain uptake) may influence the therapeutic index compared with the unformulated drug and to explore the key parameters affecting therapeutic performance using a model-based approach. Pharmacokinetic (PK) models were built with chosen PK parameters. For a scenario where central effect depends on area under the unbound brain concentration curve and peripheral toxicity relates to peak unbound plasma concentration, dose-effect and drug-side effect curves were constructed, and the therapeutic index was evaluated. Regular NC improved the therapeutic index compared with the unformulated drug due to reduced peripheral toxicity, while brain-targeting NC enhanced the therapeutic index by lowering peripheral toxicity and increasing central effect. Decreasing drug release rate or systemic clearance of NC with drug still encapsulated could increase the therapeutic index. Also, a drug with shorter half-life would therapeutically benefit more from a NC encapsulation. This work provides insights into how a NC for brain delivery should be optimized to maximize the therapeutic performance and is helpful to predict if and to what extent a drug with certain PK properties would obtain therapeutic benefit from nanoencapsulation. 相似文献
6.
目的比较2%强化戊二醛(下称戊二醛)气雾熏蒸法与浸泡消毒法消毒吸痰管的效果.方法消毒按5周期(1个周期12 d)进行,每周期将200根使用过的吸痰管经初步处理,即5% 84消毒液浸泡30 min后清水冲洗干净晾干.将每周期200根吸氮管随机均分为实验组和对照组,实验组采用戊二醛原液气雾熏蒸法消毒4 h,对照组采用戊二醛原液浸泡消毒30 min,12 d为1个周期.两组分别于第1、6、12天对消毒后的吸痰管及消毒过程中的戊二醛采样行细菌菌落数计数,并观察有无细菌生长.结果两组每周期第1、6天吸痰管和消毒液标本均未检测出细菌,且无致病微生物生长;每周期第12天对照组吸痰管和消毒液标本均检测出细菌,实验组未检测出细菌.结论气雾熏蒸法消毒灭菌效果可靠,具有节约开支、使用方便、有利于吸痰管的保存与放置等优点. 相似文献
7.
Nobuyuki Inoue Kouji Nagaike Shinichi Ishihara Mitsuhiko Nakamura Toshio Kuroshima 《Digestive endoscopy》2006,18(2):134-137
Background: For management of bowel obstruction due to colorectal cancer, endoscopic trans‐anal decompression technique has been first reported by Lelcuk et al. in 1986 using balloon dilatation technique. Since then, various types of trans‐anal decompression tubes have been clinically used for patients suffering from left side obstructing colorectal cancer as an emergent decompressing device. At present, two types of trans‐anal ileus tube (trans‐anal decompression tube) have been available for clinical use, but they have two main problems that are late colon perforations caused by the tip of the tube and tube obstruction by stool. Methods: Analysis on three late colon perforations experienced with the use of conventional devices drew possible improvements to make a trans‐anal ileus tube less harmful. To overcome the pitfalls inherent to conventional tubes, the author has developed an improved trans‐anal ileus tube with a balloon installed at the very end of the tube (‘balloon‐tipped type’) made of silicone, measuring 1200 or 1700 mm in total length and 22 Fr in outer diameter. It has been used for 12 cases with obstructing colorectal cancer etc. and its outcomes were compared with those obtained by the use of conventional trans‐anal ileus tube. Results: No late perforations have been encountered, but tube obstruction did occur in one of 12 cases. Conclusion: The new trans‐anal ileus tube with a balloon installed at the tip of ileus tube is considered to be safer and especially effective in preventing late colon perforation and tube obstruction. 相似文献
8.
Eric Paul Shaber 《International journal of oral and maxillofacial surgery》1987,16(6):678-681
Recent advances in the field of biomatrix porous implant technology has stirred the interest of the oral and maxillofacial surgical community. One such material (Medpor), is a biocompatible, large-pore, high-density polyethylene implant which has proven both experimentally and clinically to fulfil the criterion for maxillofacial reconstructive and aesthetic surgical grafting. 相似文献
9.
Zia Hossein Ma Joseph K. H. O'Donnell John P. Luzzi Louis A. 《Pharmaceutical research》1991,8(4):502-504
Dimethyl isosorbide (DMI), which is currently under investigation for its potential use as a pharmaceutical vehicle and drug permeation enhancer, is a water-miscible liquid with relatively low viscosity. The solubilization behavior of DMI as a cosolvent for nonpolar drugs was characterized via dielectric constant measurements of binary solvent systems containing DMI and either water, propylene glycol (PG), or polyethylene glycol (PEG). Evidence from the dielectric constant profiles and NMR studies suggest that DMI undergoes complexation with water and PG, but not with PEG, through hydrogen bonding interactions. The solvent complexation exhibited a major effect on the solubilities of prednisone, dexamethasone, and prednisolone in the mixed solvent systems. Maximum solubility of each drug was found to occur near a DMI/water or DMI/PG concentration ratio of 1:2. In the DMI–PEG mixed system, while there is no apparent interaction between DMI and PEG molecules, the solubility of prednisone was found to increase with decreasing dielectric constant. 相似文献
10.